Positioning Ganglioside D3 as an Immunotherapeutic Target in Lymphangioleiomyomatosis
Emily Gilbert(Loyola University Chicago), I. Caroline Le Poole(Northwestern University), Jared Klarquist(University of Colorado Anschutz Medical Campus), Adam M. Hammer(Loyola University Chicago), Jonathan M. Eby, Daniel F. Dilling, Maria M. Picken(Loyola University Medical Center), Raymond E. Boissy(University of Cincinnati), Robert B. Love(Loyola University Chicago), David G. Christensen(Loyola University Chicago), Allison Barfuss(Loyola University Chicago)
Cited by 15
Related Papers
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
|The Lancet Respiratory Medicine|2020|558
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Diagnosis of monoclonal gammopathy of renal significance
|Kidney International|2015|421
Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories
|American Journal of Respiratory and Critical Care Medicine|2019|226